Appointment of Chief Financial Officer

RNS Number : 6279X
Venture Life Group PLC
01 May 2019

1 May 2019

Venture Life Group plc

("Venture Life" or the "Group")

Appointment of Chief Financial Officer

Venture Life Group plc (AIM: VLG), a leader in developing, manufacturing and commercialising products for the international self-care market, today announces that it has appointed Andrew Waters, FCA, to the Board of Venture Life as Chief Financial Officer with immediate effect. 

Andrew has been working closely with the Board since February 2019 after the departure of former CFO, Adrian Crockett, earlier this year. Andrew is a Chartered Accountant having previously worked at PWC and then GlaxoSmithKline plc, where he spent 16 years in various financial and business management positions. Following this, Andrew co-founded two businesses, Cubase Consulting Ltd and Infirst Healthcare Ltd, which he led through three successful funding rounds, raising in excess of £40 million from private equity.

Dr Lynn Drummond, Chair of Venture Life, said: "We are delighted to welcome Andrew to the Board of Venture Life. Andrew brings a range of skills to the team to support the ambitious plans we have for the business over the coming years. I am confident Andrew will be a valuable and complementary addition to the executive team."


Disclosures required by Schedule 2(g) of the AIM Rules for Companies

In the past 5 years, Mark Andrew Waters, aged 52, has held the following positions where he was acting in the capacity of a Director:

Current Directorships:

Cubase Consulting Ltd

AW Chartered Accountant

Past Directorships:

Infirst Healthcare Ltd

Infirst Healthcare Inc (USA)

Infirst Healthcare Ltd (Ireland) (formerly Immunocopea Ltd)

Respicopea Holding Ltd


Andrew Waters does not have any interest in the ordinary shares of the Company.

There are no further disclosures to be made pursuant to Schedule Two, paragraph (g) of the AIM Rules for Companies.

For further information, please contact:

Venture Life Group PLC

+44(0) 1344 578004

Jerry Randall, Chief Executive Officer

Cenkos Securities Ltd (Nomad and Broker)

+44(0)20 7397 8900

Mark Connelly / Stephen Keys / Cameron MacRitchie (Corporate Finance)

Russell Kerr / Michael Johnson (Sales)


 Alma PR

 +44(0)20 3405 0208

 Rebecca Sanders-Hewett / Hilary Buchanan / Helena Bogle / Jessica Joynson




About Venture Life (

Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the global self-care market. With operations in both the UK and Italy, the Group's product portfolio includes some key products such as the UltraDEX and Dentyl oral care product ranges, food supplements for maintaining brain function, medical devices for women's intimate healthcare and proctology and dermo-cosmetics for addressing the signs of ageing.

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies and grocery multiples. In the UK these are supplied direct by the company, outside of the UK they are supplied by the Group's international distribution partners. 

Through its Development & Manufacturing business in Italy, Biokosmes, the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors.





This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit
UK 100

Latest directors dealings